ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,516Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 113

$532K Total Retail Price of All Prescriptions

Rank: 26 out of 113

507 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 507 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 507 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 7,240 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 482 381 1 1
HYDROCODONE-ACETAMINOPHEN 435 265 S3 2 7
SIMVASTATIN 409 330 3 2
WARFARIN SODIUM 346 256 4 8
LISINOPRIL 335 302 5 3
FUROSEMIDE 261 247 6 6
HYDROCHLOROTHIAZIDE 243 229 7 9
AMLODIPINE BESYLATE 240 220 8 4
METOPROLOL TARTRATE 200 167 9 14
OMEPRAZOLE 193 146 10 5
METFORMIN HCL 175 142 11 11
SERTRALINE HCL 154 126 12 21
ZOLPIDEM TARTRATE 153 103 13 19
POTASSIUM CHLORIDE 152 141 14 12
TAMSULOSIN HCL 150 136 15 24
ATORVASTATIN CALCIUM 141 103 16 15
ALLOPURINOL 130 110 17 20
GABAPENTIN 123 60 18 18
ATENOLOL 112 89 19 16
TRAZODONE HCL 98 59 20 41
LOSARTAN POTASSIUM 93 79 21 13
SPIRIVA 81 76 22 54
ADVAIR DISKUS 80 55 23 35
METOPROLOL SUCCINATE 77 70 24 10
COMBIVENT 72 71 25 99
ALENDRONATE SODIUM 72 72 25 22
MORPHINE SULFATE ER 67 16 S2 27 79
VENTOLIN HFA 66 50 28 110
DIGOXIN 66 66 28 27
NAMENDA 64 64 30 48
CARVEDILOL 63 60 31 25
CRESTOR 61 53 32 30
TRIAMTERENE-HCTZ 59 57 33 26
DILTIAZEM ER 58 35 34 92
PRAVASTATIN SODIUM 58 55 34 23
OXYCODONE HCL 58 20 S2 34 62
CITALOPRAM HBR 57 53 37 17
NEXIUM 55 26 38 47
LANTUS SOLOSTAR 54 35 39 59
FLUTICASONE PROPIONATE 53 46 40 39
AMITRIPTYLINE HCL 51 21 R 41 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.